Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Nutanix Inc (NTNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Nutanix Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Nutanix Inc trades at $69.78 (market cap $18.90B). The key difference: Nutanix Inc is far larger — about 2.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Nutanix Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Nutanix Inc for 17 Days on average.
| IONS | NTNX | |
|---|---|---|
Market Cap | $7.10B | $18.90B |
Volume | 2,027,457 | 3,504,387 |
Sector | Health | Technology |
52-Week High | $86.50 | $74.63 |
52-Week Low | $42.38 | $34.41 |
Typical Hold Time | 0 Days | 17 Days |
Enterprise Value | $6.66B | $18.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nutanix (NTNX) trades at $72.88, down 1.7% on the day but maintains strong technical momentum with bullish moving averages and recent earnings beats. The company reported robust Q4 2026 results exceeding expectations, with revenue growth to $2.9B and net profit margin expanding to 52.8%. Recent Gartner Magic Quadrant recognitions highlight competitive strength in virtualization and container management platforms.
Outlook remains positive with 62.5% analyst buy ratings and $76.11 consensus price target, though elevated P/S ratio and negative ROE warrant monitoring. Key risks include supply chain pressures and competitive threats in cloud infrastructure, while AI growth initiatives present long-term opportunity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →
